Ipca Laboratories Ltd Share Price (IPCALAB)
Check the latest share price of Ipca Laboratories Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 13 Jun 2025
NSE
Ipca Laboratories Ltd Stock Performance
Get live Ipca Laboratories Ltd share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹1,353.2Day's Price Range₹1,379.252 Week's Low
52 Week's High
₹1,05252-Week Price Range₹1,755.9
| Returns % | |
| 1 Month Return | -3.53 % |
| 3 Month Return | + 3.85 % |
| 1 Year Return | + 15.83 % |
| 3 Year Return | + 58.08 % |
| 5 Year Return | + 71.1 % |
| Market Stats | |
| Previous Close | ₹1,383.00 |
| Open | ₹1,368.90 |
| Volume | 2.80L |
| Upper Circuit | ₹1,659.60 |
| Lower Circuit | ₹1,106.40 |
Ipca Laboratories Ltd Fundamentals & Key Indicators
Check Ipca Laboratories Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹34,716.89 Cr
Return on Equity (ROE)
9.81
PE Ratio (TTM)
47.06
Return on capital employed (ROCE)
14.12
Industry PE ratio
57.39
Beta (LTM)
0.87
P/B Ratio
4.95
Dividend Yield
0.32
PEG Ratio
6.27
Quarterly Earnings Growth YOY
2160.48
EPS (TTM)
20.86
Sector
Pharmaceuticals
Book Value
249.59
Technical Analysis
Bearish
View Technical Analysis
How to invest in Ipca Laboratories Ltd?
Investing in Ipca Laboratories Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Ipca Laboratories Ltd or IPCALAB on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Ipca Laboratories Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Ipca Laboratories Ltd with just a few clicks!
Ipca Laboratories Ltd Stock's Interest Amongst Investors
Ipca Laboratories Ltd Valuation
Track how Ipca Laboratories Ltd P/E has moved over time to understand its valuation trends.
Ipca Laboratories Ltd in the last 5 years
Lowest (18.72x)
October 10, 2019
Today (47.06x)
June 13, 2025
Industry (57.39x)
June 13, 2025
Highest (65.89x)
September 25, 2024
Today’s Price to Earnings Ratio: 47.06x
Ipca Laboratories Ltd Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Ipca Laboratories Ltd.
based on 21 analysts
60.00%
Buy
20.00%
Hold
20.00%
Sell
60% of analysts recommend a 'BUY' rating for Ipca Laboratories Ltd. Average target price of ₹1540.67
Source: S&P Global Market Intelligence
Ipca Laboratories Ltd Share Price Target
Get share price movements and forecasts by analysts on Ipca Laboratories Ltd.
Ipca Laboratories Ltd price forecast by 21 analysts
Upside of12.59%
High
₹1918
Target
₹1540.67
Low
₹900
Ipca Laboratories Ltd target price ₹1540.67, a slight upside of 12.59% compared to current price of ₹1368.4. According to 21 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Ipca Laboratories Ltd revenue growth forecast
Expected growth rate Q1, FY2027:43.28%
Forecast
Actual
Including amortisation and stock based compensations
Ipca Laboratories Ltd EPS growth forecast
EPS estimate Q1, FY2027:149.88%
Forecast
Actual
Source: S&P Global Market Intelligence
Ipca Laboratories Ltd Financial Results
Get the annual and quarterly financial summary of Ipca Laboratories Ltd, including revenue, profit, loss and more.
Indices Featuring Ipca Laboratories Ltd Stock
Check stock indices that include Ipca Laboratories Ltd.
Ipca Laboratories Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Ipca Laboratories Ltd.
Ipca Laboratories Ltd Earnings Results
Ipca Laboratories Ltd’s net profit jumped 13.81% since last year same period to ₹67.82Cr in the Q4 2024-2025. On a quarterly growth basis, Ipca Laboratories Ltd has generated -72.67% fall in its net profits since last 3-months.
Read More about Earnings ResultsIpca Laboratories Ltd Dividends November,2024
In the quarter ending September 2024, Ipca Laboratories Ltd has declared dividend of ₹2 - translating a dividend yield of 0.29%.
Read More about Dividends
Ipca Laboratories Ltd Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Ipca Laboratories Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 44.72% | 0.00 | |
| Foreign Institutions | 10.76% | 0.00 | |
| Mutual Funds | 29.63% | 0.00 | |
| Retail Investors | 8.46% | 0.00 | |
| Others | 6.43% | 0.00 |
Ipca Laboratories Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Ipca Laboratories Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 34,716.89 | 14.22% | 0.58 | 529 | 7,705 | |
| BUY | 14,157.69 | -4.54% | 0.52 | 413 | 2,013 | |
| BUY | 67,394.66 | 9.93% | 0.56 | 3,168 | 29,001 | |
| HOLD | 98,102.78 | 32.58% | 0.64 | 3,854 | 19,547 | |
| BUY | 66,969.38 | 19.17% | 0.53 | NA | NA |
Ipca Laboratories Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Ipca Laboratories Ltd.
Ipca Laboratories Continues Upward Trend - 12 Jun, 2025
Ipca Laboratories Ltd gained 1.25% on June 12, 2025, marking its third consecutive session of gains. The stock is currently priced at Rs 1406.8, with a 17.25% increase over the past year, outperforming both NIFTY and Nifty Pharma index. The stock has seen a slight increase of 0.19% in the last month.Ipca Labs Reports Mixed Financial Results for March 2025 - 10 Jun, 2025
Ipca Laboratories reported net sales of Rs 1,638.44 crore for March 2025, an 8.46% increase year-on-year. However, the company faced a net loss of Rs 65.05 crore, a significant decline from the previous year. EBITDA rose by 23.63%. Shares closed at Rs 1,369.30, reflecting a -10.14% return over six months but a 16.37% gain over the past year.Ipca Laboratories Reports Mixed Q4FY25 Performance - 04 Jun, 2025
Ipca Laboratories' Q4FY25 results were in line with expectations, showing strong growth in the India and export segments. However, margins fell short, leading to a 5% EPS revision for FY26. The company maintains a positive outlook for sustained growth despite challenges in South Africa and inventory issues in Australia and New Zealand.Ipca Laboratories Shares Decline Amid Financial Fluctuations - 03 Jun, 2025
Ipca Laboratories' stock fell by 2.08% to Rs 1,386.30, reflecting investor sentiment amid fluctuating net profits despite consistent revenue growth over the years.IPCA Laboratories Faces Mixed Analyst Ratings - 02 Jun, 2025
IPCA Laboratories experiences mixed analyst sentiments with HSBC downgrading its target price to Rs 1,330, while Nomura maintains a Buy rating at Rs 1,590. Prabhudas Lilladher suggests an Accumulate rating with a target of Rs 1,525, despite lower revenue growth guidance from management.Ipca Laboratories Reports Strong Q4FY25 Financials - 30 May, 2025
Ipca Laboratories announced a 13.8% year-on-year increase in net profit to Rs 67.8 crore for Q4FY25, with revenue rising 10.5% to Rs 2,246.7 crore and EBITDA surging 33.2%. Margins expanded to 19.09%.Ipca Laboratories Reports Strong Q4 Earnings and Dividend - 29 May, 2025
Ipca Laboratories reported a 14% increase in Q4 net profit to ₹68 crore and a 10.5% rise in revenue. The company announced a final dividend of ₹2 per share for FY 2024-25, reflecting strong financial performance.
Insights on Ipca Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 2.26K Cr → 2.27K Cr (in ₹), with an average increase of 0.3% per quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 44.72% of holdings in Mar 2025 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 45.3% return, outperforming this stock by 29.5%
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.1% return, outperforming this stock by 73.0%
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 11.07% to 10.76% in Mar 2025 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 248.14 Cr → 67.82 Cr (in ₹), with an average decrease of 72.7% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, IPCALAB stock has moved down by -3.5%
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 8.53% to 8.46% in Mar 2025 quarter
About Ipca Laboratories Ltd
Revenue: ₹2,246.69Cr as on March 2025 (Q4 FY25)
Net Profit: ₹65.78Cr as on March 2025 (Q4 FY25)
Listing date: 03 Nov, 1994
Chairperson Name: Premchand Godha
| Organisation | Ipca Laboratories Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | Premchand Godha |
| E-voting on shares | Click here to vote |
Mutual Funds that own Ipca Laboratories Ltd
Check out the Mutual Funds with significant holdings in Ipca Laboratories Ltd.
FAQs
What is Ipca Laboratories Ltd share price today?
Ipca Laboratories Ltd share price today stands at ₹1368.4, Open: ₹1368.9, Previous Close: ₹1383, High: ₹1379.2, Low: ₹1353.2, 52 Week High: ₹1755.9, 52 Week Low: ₹1052.
What is today's traded volume of Ipca Laboratories Ltd?
Today's traded volume of Ipca Laboratories Ltd is 2.80L. Which means that 2.80L shares of Ipca Laboratories Ltd were bought and sold on the stock market during today's trading session.
What is Ipca Laboratories Ltd's market cap today?
Today's market capitalisation of Ipca Laboratories Ltd is ₹34,716.89 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Ipca Laboratories Ltd?
Ipca Laboratories Ltd’s 52 week high is ₹1755.9 and 52 week low is ₹1052. The current share price of Ipca Laboratories Ltd is ₹1368.4, which is -22.07% down from its 52 week high and 30.08% up from its 52 week low.